HighMark Wealth Management
HighMark Wealth Management reported 562 stocks worth $299M in its 13F filing for Q2 2026, filed Aug 12, 2026. Its largest holdings are IVV (27.6%), FHLC (6.6%) and AXGN (5.3%). Compared with Q1 2026, the fund opened new positions in DUOT, OKE and SNDK, added to FHLC, NEO and SIBN, trimmed IVV, AXGN and IWM and sold out of STX, GLOB and PAYC.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  IVV Ishares TR | $82.3M | 27.6% | 110K | −7,063 (−6%) | 8 of 8 | |
| 2 |  FHLC Fidelity Msci Health Care Index ETF | $19.7M | 6.6% | 254K | +254K (+3179938%) | 8 of 8 | |
| 3 |  AXGN Axogen Inc | $15.8M | 5.3% | 341K | −3,550 (−1%) | 8 of 8 | |
| 4 |  IWM Ishares TR | $15.3M | 5.1% | 51K | −3,597 (−7%) | 8 of 8 | |
| 5 |  EFV Ishares TR | $15.2M | 5.1% | 199K | −21K (−10%) | 8 of 8 | |
| 6 |  IJR Ishares TR | $13.3M | 4.5% | 90K | −797 (−1%) | 8 of 8 | |
| 7 |  VOO Vanguard S&P 500 ETF | $10.7M | 3.6% | 16K | −982 (−6%) | 8 of 8 | |
| 8 |  NEO Neogenomics Inc | $8.9M | 3.0% | 613K | +33K (+6%) | 8 of 8 | |
| 9 |  IUSV Ishares TR | $8.3M | 2.8% | 76K | −5,033 (−6%) | 8 of 8 | |
| 10 |  SIBN Si-Bone Inc | $6.9M | 2.3% | 425K | +265K (+166%) | 8 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
CENTESSA PHARMACEUTICALS PLC | $9.4M | 237K |
 STX Seagate Technology Hldngs PL | $39K | 100 |
 GLOB Globant S A | $25K | 547 |
 PAYC Paycom Software Inc | $23K | 187 |
 APYX Apyx Medical Corporation | $18K | 5,000 |
🔒 Free account: see all 30.
Options
valued at the underlying shares| Stock | Type | Value | Shares | Change |
|---|---|---|---|---|
 DFTX Definium Therapeutics Inc | Call | $265 | 1 | +1 |
WENDYS CO | Call | $60 | 1 | +1 |
STATE STR SPDR S&P 500 ETF T | Put | $19 | 19 | +19 |
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 12, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →HighMark Wealth Management 13F FAQ
What does HighMark Wealth Management own?
HighMark Wealth Management reported 562 stocks worth $299M in its 13F filing for Q2 2026, filed Aug 12, 2026. Its largest holdings are IVV (27.6%), FHLC (6.6%) and AXGN (5.3%). The table above lists every position in the filing (the top 10 without an account).
What did HighMark Wealth Management buy and sell in Q2 2026?
Compared with Q1 2026: 45 new positions, 155 added to, 91 trimmed and 38 sold out. New positions include DUOT, OKE and SNDK. It sold all of STX, GLOB and PAYC.
When will HighMark Wealth Management file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is HighMark Wealth Management's portfolio worth?
The Q2 2026 filing reports $299M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.